Greenville (S.C.) Health System announced that an unusual infection, caused by an atypical mycobacterium, was found in 14 surgical patients at the Greenville Memorial Medical Campus.

A new app released by the University of Nebraska Medical Center is addressing antimicrobial resistance by providing point of care access to antimicrobial usage guidelines.

Here are the top stories on infection control and clinical quality from Becker's Hospital Review for the week of June 16, beginning with the most accessed.

The FDA has approved Cubist Pharmaceuticals' new drug, Sivextro, for the treatment of acute bacterial skin infections, including those caused by methicillin-resistant Staphylococcus aureus.

Five New England states have partnered to form an interstate prescription registry to better track the distribution of controlled substances and help prevent patients from collecting prescriptions from multiple physicians without their knowledge, according to a Reuters report.

The spread of methicillin resistant Staphylococcus aureus has led to a giant increase in the number of skin and soft tissue infections, according to the Infectious Diseases Society of America. This surge of SSTIs led the IDSA to publish updated…

  The National Patient Safety Foundation announced new appointments to its board of governors, effective July 1.

Austen BioInnovation Institute and OMNOVA Solutions announced that teams from both organizations have started working on a pioneering project to explore the interactions between disinfectants and common health facility surfaces.

The American Society for Radiation Oncology and American Association of Physicists in Medicine announced the creation of RO-ILS: Radiation Oncology Incident Learning System, a new patient safety organization.

  Medline announced that it will reopen a facility in Hartland, Wis., and plans to use it to produce infection control and prevention products, according to a Milwaukee Business Journal report.